Blinatumomab plus dasatinib in a dialysis-dependent patient with ph-positive B-ALL: Durable MRD-negative remission
Year: 2025
Type: conference-abstract
Source: Blood
Institution: Baylor College of Medicine
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417002698
Cites:
Cited by:
Related to:
